You are here

  • Home
  • Archive
  • Volume 5, Issue 1
  • Pioglitazone and risk of mortality in patients with type 2 diabetes: results from a European multidatabase cohort study

Article metrics

Article menu

Download PDFPDF

XML
Epidemiology/Health Services Research
Pioglitazone and risk of mortality in patients with type 2 diabetes: results from a European multidatabase cohort study

 

Online download statistics by month:

Online download statistics by month: May 2017 to March 2024

AbstractFullPdf
May 2017018150
Jun 201780347210
Jul 201715815468
Aug 201717116890
Sep 201715014958
Oct 201710010035
Nov 201713112930
Dec 201710010037
Jan 201813513745
Feb 201812711035
Mar 201816316038
Apr 2018929226
May 20189810218
Jun 2018798117
Jul 2018797943
Aug 2018858543
Sep 2018888853
Oct 201810010054
Nov 201813413444
Dec 201815815840
Jan 201914214050
Feb 201912912935
Mar 2019999938
Apr 2019858546
May 2019979343
Jun 2019929342
Jul 201910110137
Aug 2019747232
Sep 201922822043
Oct 201910310053
Nov 2019959352
Dec 2019939154
Jan 202010610634
Feb 2020868543
Mar 2020787747
Apr 2020555527
May 2020323226
Jun 2020474538
Jul 2020444330
Aug 2020514632
Sep 2020625728
Oct 2020737043
Nov 2020595719
Dec 2020625925
Jan 2021635929
Feb 2021656536
Mar 2021717036
Apr 2021686830
May 2021696632
Jun 2021444330
Jul 2021474729
Aug 2021484722
Sep 2021565338
Oct 2021393739
Nov 2021393643
Dec 2021535419
Jan 2022444412
Feb 2022494812
Mar 2022747523
Apr 2022686218
May 2022464620
Jun 2022323420
Jul 2022242416
Aug 2022242315
Sep 2022312824
Oct 2022333822
Nov 2022534625
Dec 2022282721
Jan 2023343319
Feb 2023535218
Mar 2023313216
Apr 2023424018
May 2023232212
Jul 2023414214
Aug 2023333218
Sep 202333355
Oct 202340417
Nov 202336345
Dec 202345469
Jan 202438356
Feb 202418179
Mar 20242019141
Total597663222859